In the Czech Republic, the pharmaceuticals,medicinal chemicals, seasonally adjusted index currently stands at 172.9, reflecting an increase of 4.8 (2.9%) compared to 2023 Q4.
Pharmaceuticals,medicinal chemicals, seasonally adjusted index in the Czech Republic
No matching regions
Data currently not available for this time and region, try a different time period
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to the Czech Republic
Pharmaceuticals,medicinal chemicals
More indicators for the Czech Republic
Czech Republic Pharmaceuticals,medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals,medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 172.9 | 4.8 |
| 2023 Q4 | 168.1 | 0.5 |
| 2023 Q3 | 168.6 | 17.1 |
| 2023 Q2 | 185.7 | 18.4 |
| 2023 Q1 | 167.3 | 3.9 |
| 2022 Q4 | 163.4 | 4.5 |
| 2022 Q3 | 167.9 | 11.9 |
| 2022 Q2 | 156.0 | 2.3 |
| 2022 Q1 | 158.3 | 1.7 |
| 2021 Q4 | 156.6 | 6.7 |
| 2021 Q3 | 149.9 | 2.8 |
| 2021 Q2 | 147.1 | 6.2 |
| 2021 Q1 | 153.3 | 1.9 |
| 2020 Q4 | 155.2 | 13.1 |
| 2020 Q3 | 142.1 | 2.1 |
| 2020 Q2 | 144.2 | 1.5 |
| 2020 Q1 | 145.7 | 2.4 |
| 2019 Q4 | 148.1 | 1.2 |
| 2019 Q3 | 146.9 | 7.4 |
| 2019 Q2 | 139.5 | 3.3 |
| 2019 Q1 | 136.2 | 13.0 |
| 2018 Q4 | 123.2 | 0.9 |
| 2018 Q3 | 124.1 | 7.1 |
| 2018 Q2 | 117.0 | 1.8 |
| 2018 Q1 | 118.8 | 7.9 |
| 2017 Q4 | 110.9 | 6.2 |
| 2017 Q3 | 117.1 | 5.3 |
| 2017 Q2 | 122.4 | 15.7 |
| 2017 Q1 | 106.7 | 1.4 |
| 2016 Q4 | 105.3 | 0.1 |
| 2016 Q3 | 105.2 | 0.3 |
| 2016 Q2 | 104.9 | 6.6 |
| 2016 Q1 | 98.3 | 8.5 |
| 2015 Q4 | 106.8 | 7.1 |
| 2015 Q3 | 99.7 | 3.5 |
| 2015 Q2 | 96.2 | 1.1 |
| 2015 Q1 | 97.3 | 2.1 |
| 2014 Q4 | 95.2 | 2.9 |
| 2014 Q3 | 92.3 | 5.9 |
| 2014 Q2 | 86.4 | 12.6 |
| 2014 Q1 | 99.0 | 3.5 |
| 2013 Q4 | 95.5 | 4.1 |
| 2013 Q3 | 99.6 | 13.4 |
| 2013 Q2 | 86.2 | 2.5 |
| 2013 Q1 | 88.7 | 2.3 |
| 2012 Q4 | 86.4 | 0.4 |
| 2012 Q3 | 86.8 | 2.2 |
| 2012 Q2 | 84.6 | 5.6 |
| 2012 Q1 | 90.2 | 0.1 |
| 2011 Q4 | 90.3 | 1.2 |
| 2011 Q3 | 91.5 | 0.6 |
| 2011 Q2 | 90.9 | 3.2 |
| 2011 Q1 | 94.1 | 1.0 |
| 2010 Q4 | 93.1 | 0.6 |
| 2010 Q3 | 93.7 | 4.3 |
| 2010 Q2 | 89.4 | 1.2 |
| 2010 Q1 | 90.6 | 5.9 |
| 2009 Q4 | 84.7 | 3.0 |
| 2009 Q3 | 81.7 | 3.9 |
| 2009 Q2 | 77.8 | 4.1 |
| 2009 Q1 | 81.9 | 3.0 |
| 2008 Q4 | 84.9 | 3.2 |
| 2008 Q3 | 88.1 | 0.9 |
| 2008 Q2 | 87.2 | 2.8 |
| 2008 Q1 | 90.0 | 2.5 |
| 2007 Q4 | 87.5 | 2.8 |
| 2007 Q3 | 90.3 | 1.2 |
| 2007 Q2 | 89.1 | 4.7 |
| 2007 Q1 | 93.8 | 2.7 |
| 2006 Q4 | 91.1 | 2.6 |
| 2006 Q3 | 88.5 | 6.2 |
| 2006 Q2 | 82.3 | 1.8 |
| 2006 Q1 | 84.1 | 1.8 |
| 2005 Q4 | 82.3 | 2.6 |
| 2005 Q3 | 79.7 | 3.7 |
| 2005 Q2 | 76.0 | 1.3 |
| 2005 Q1 | 74.7 |